Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The main goals of the study are: Assessment of Tygacil's cost-effectiveness; Process cost
analysis from a hospital perspective (including length of stay, treatment costs, side effect
management costs, costs of monitoring, costs of diagnostic procedures, cost of care (TISS 10
score etc.); Efficacy of Tygacil under usual care conditions (cure rate).